CICERO, ARRIGO FRANCESCO GIUSEPPE
CICERO, ARRIGO FRANCESCO GIUSEPPE
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di IIa fascia
Cicero A.; A. Cicero.; Cicero A.F.G.; A.F.G. CICERO; CICERO A.F.; Cidero AFG; CICERO AFC; Arrigo F.G. Cicero; CICERO FA
Pharmanutrition and Functional food
In corso di stampa Arrigo F.G. Cicero
Comparison Between a Single-Lead ECG Garment Device and a Holter Monitor: A Signal Quality Assessment
2024 Neri L.; Corazza I.; Oberdier M.T.; Lago J.; Gallelli I.; Cicero A.F.G.; Diemberger I.; Orro A.; Beker A.; Paolocci N.; Halperin H.R.; Borghi C.
Diabetic Cardiomyopathy: 2023 Update by the International Multidisciplinary Board of Experts
2024 Avagimyan A, Fogacci F, Pogosova N, Kakrurskiy L, Kogan E, Urazova O, Kobalava Z, Mikhaleva L, Vandysheva R, Zarina G, Trofimenko A, Navasardyan G, Mkrtchyan L, Galli M, Jndoyan Z, Aznauryan A, Saahakyan K, Agati L, Shafie D, Cicero A, Salvo GD, Sarrafzadegan N
Adherence to the Mediterranean Diet Association with Serum Inflammatory Factors Stress Oxidative and Appetite in COVID-19 Patients
2023 Mohajeri M, Mohajery R, Cicero AFG.
Adherence to the Mediterranean Diet Association with Serum Levels of Nitric Oxide, Prostacyclin, and Thromboxane B2 among Prinzmetal Angina Patients and Healthy Persons
2023 Mohajeri Mahsa; Cicero Arrigo
An Evolving Definition of a “Healthy Diet”
2023 Cicero AFG, Fogacci F, Borghi C.
An Expert Opinion on the Role of the Rosuvastatin/Amlodipine Single Pill Fixed Dose Combination in Cardiovascular Prevention
2023 Gallo G, Sarzani R, Cicero AFG, Genovese S, Pirro M, Gallelli L, Faggiano A, Volpe M.
Assessment of Apolipoprotein(a) Isoform Size Using Phenotypic and Genotypic Methods
2023 Fogacci F, Di Micoli V, Avagimyan A, Giovannini M, Imbalzano E, Cicero AFG
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events.
2023 Raschi E, Casula M, Cicero AFG, Corsini A, Borghi C, Catapano A.
Concordance of LDL-C Estimating Equations with Direct Enzymatic Measurement in Diabetic and Prediabetic Subjects
2023 Bolat S, Ertürk Zararsız G, Doğan K, Kochan N, Yerlitaş SI, Cephe A, Zararsız G, Cicero AFG
Editorial: Data driven and model based computational futures in cardiovascular practice
2023 Bauer R, Cicero AFG, Manca M
Editorial: Serum uric acid, vascular aging, and endocrine comorbidities
2023 Hu Y; Cicero AFG.
Effect of Citrus bergamia extract on lipid profile: A combined in vitro and human study
2023 Pierdomenico M, Cicero AFG, Veronesi M, Fogacci F, Riccioni C, Benassi B
Effect of dietary supplementation with Diuripres® on blood pressure, vascular health, and metabolic parameters in individuals with high-normal blood pressure or stage I hypertension: The CONDOR randomized clinical study
2023 Fogacci F, Degli Esposti D, Di Micoli A, Fiorini G, Veronesi M, Borghi C, Cicero AFG.
Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study
2023 Ehlrich A, Ioannidis K. Nasar M., Alkian IA, Daskal Y, Atari N, Kliker L, Rainy N, Hofree M, Tikva SS, Houri I, Cicero AF, Pavanello C, Sirtori CI, CohenJB, Chirinos JA, Deutsch L, Cohen M, Gottlieb A, Bar-Chaim A, Shibolet O, Mandelboim M, Maayan S, Nahmias Y.
Hyperuricemia increases the risk of cardiovascular mortality associated with very high HdL-cholesterol level.
2023 Palatini P, Virdis A, Masi S, Mengozzi A, Casiglia E, Tikhonoff V, Cicero AFG, Ungar A, Parati G, Rivasi G, Salvetti M, Barbagallo CM, Bombelli M, Dell'Oro R, Bruno B, Lippa L, D'Elia L, Masulli M, Verdecchia P, Reboldi G, Angeli F, Mallamaci F, Cirillo M, Rattazzi M, Cirillo P, Gesualdo L, Mazza A, Giannattasio C, Maloberti A, Volpe M, Tocci G, Iaccarino G, Nazzaro P, Galletti F, Ferri C, Desideri G, Viazzi F, Pontremoli R, Muiesan ML, Grassi G, Borghi C; from the Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA).
Impact of anti-oestrogen therapy on lipoprotein(a) in postmenopausal women: a systematic review and meta-analysis of double-blind placebo-controlled clinical studies.
2023 Fogacci F, Borghi C, Davinelli S, Scapagnini G, Cicero AFG.
LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionals
2023 Poli A, Catapano AL, Corsini A, Manzato E, Werba JP, Catena G, Cetin I, Cicero AFG, Cignarella A, Colivicchi F, Consoli A, Landi F, Lucarelli M, Manfellotto D, Marrocco W, Parretti D, Perrone Filardi P, Pirillo A, Sesti G, Volpe M, Marangoni F
Metabolic and vascular effect of a new standardized bergamot phytocomplex: a three-arm, placebocontrolled, double-blind clinical trial
2023 Fogacci F, Giovannini M, Imbalzano E, Grandi E, Rizzoli E, D'Addato S, Cicero AFG
Mushroom-Based Supplements in Italy: Let’s Open Pandora’s Box
2023 Risoli S, Nali C, Sarrocco S, Cicero AFG, Colletti A, Bosco F, Venturella G, Gadaleta A, Gargano ML, Marcotuli I.